revenue guidance

Law firm Kirby McInerney LLP reminds Upstart investors of June 8, 2026 deadline to join securities lawsuit alleging the company's Model 22 AI overstated accuracy and loan approvals.

Class action lawsuit filed against $MNDY alleging materially false 2027 revenue guidance. Stock plummeted 33% after company rescinded $1.8B target and warned of growth slowdown.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI tool's accuracy and market impact during May-November 2025 period.

Palantir stock surged 3.52% after announcing Army collaboration and raising 2026 revenue guidance to $7.65-7.66B, beating estimates. Government growth hit 84% YoY.

Four companies face securities fraud investigations alleging executive misstatements about valuations, acquisitions, and revenue prospects. Eligible shareholders may seek compensation at no upfront cost.

Class action lawsuit filed against $SES AI for alleged securities fraud involving false statements and inflated revenue. Stock crashed 36.8% after disappointing 2026 guidance.

SES AI Corporation faces securities fraud lawsuit alleging revenue inflation through related-party transactions and undisclosed logistics constraints, with stock down 37%.

Pfizer beats Q1 2026 expectations with $0.75 EPS and $14.45B in sales. Patent settlement extends Vyndamax protection to June 2031, ensuring revenue stability.

Broadcom projects $100B AI revenue by 2027, but elevated 80.6 P/E valuation leaves minimal room for execution error as competition intensifies.

SES AI faces securities fraud lawsuit alleging false statements, overstated deals, and customer losses. Stock fell 36.8% to $1.08 after Wolfpack Research report.

SES AI stock crashes 37% to $1.08 after securities fraud probe launched over alleged concealment of customer losses and questionable acquisition.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI underwriting capabilities and inflated performance metrics.

Class action lawsuit filed against $UPST alleging AI Model 22 overstated accuracy and overreacted to economic signals, triggering 9.7% stock decline after missed guidance.

MaxLinear beats Q1 earnings estimates and guides Q2 revenue significantly above expectations, fueled by 130% infrastructure segment growth from AI data center demand.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI underwriting capabilities and overstated accuracy rates during May-November 2025 period.

ServiceNow beat Q1 earnings, raising guidance by $205M, but stock plunged 14% after CFO warned Middle East tensions could delay deal closures.

ASML raises 2026 revenue guidance to €38B on AI demand, predicts memory shortages. Bullish signal for Micron Technology stock, which gained 60% YTD.

Upstart Holdings faces class action lawsuit alleging false claims about its AI Model 22 risk assessment tool. Investors can join until June 8, 2026.

Rosen Law Firm files UPST class action over Model 22 AI misrepresentations. Alleged false claims about accuracy rates and macroeconomic model sensitivity impact investor viability.

Robbins LLP filed class action against $UPST alleging misleading statements about AI lending model accuracy and revenue guidance, following Q3 miss and 9.71% stock decline.